Insider trading

Period: 120 months Stock: ARVN Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

104 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

104 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

104 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

104 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
104 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
104 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

104 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 Jun 2026
Saik Andrew Chief Financial Officer
Sold on a plan
$46.47K 5,696 at 8.16
2.9%
Planned (10b5-1)
17 Jun 2026
Cacace Angela M Chief Scientific Officer
Sold on a plan
$19.56K 2,576 at 7.60
1.4%
Planned (10b5-1)
21 May 2026
Teel Randy President and CEO
Sold at will
$19.96K 2,209 at 9.04
0.8%
Not planned
11 May 2026
Saik Andrew Chief Financial Officer
Sold at will
$110.69K 11,139 at 9.94
5.5%
Not planned
11 May 2026
Berkowitz Noah Chief Medical Officer
Sold at will
$110.38K 11,108 at 9.94
5.5%
Not planned
11 May 2026
Teel Randy President and CEO
Sold at will
$95.97K 9,657 at 9.94
3.3%
Not planned
11 May 2026
Cacace Angela M Chief Scientific Officer
Sold at will
$95.97K 9,657 at 9.94
5.0%
Not planned
11 May 2026
Loomis David K VP, Chief Accounting Officer
Sold at will
$19.07K 1,919 at 9.94
4.6%
Not planned
18 Mar 2026
Berkowitz Noah Chief Medical Officer
Sold at will
$71.43K 6,435 at 11.10
3.1%
Not planned
27 Feb 2026
Houston John G Director
Sold at will 3×
$466.15K 35,297 at 13.21
3.0%
Not planned
23 Feb 2026
Teel Randy President and CEO
Sold at will 2×
$58.20K 4,786 at 12.16
3.1%
Not planned
23 Feb 2026
Cacace Angela M Chief Scientific Officer
Sold at will 2×
$43.89K 3,609 at 12.16
2.4%
Not planned
23 Feb 2026
Loomis David K Chief Accounting Officer
Sold at will
$13.47K 1,108 at 12.16
3.6%
Not planned
13 Feb 2026
Berkowitz Noah Chief Medical Officer
Sold at will
$67.59K 5,685 at 11.89
3.4%
Not planned
13 Feb 2026
Saik Andrew Chief Financial Officer
Sold at will
$61.04K 5,134 at 11.89
3.1%
Not planned
13 Feb 2026
Cacace Angela M Chief Scientific Officer
Sold at will
$54.60K 4,592 at 11.89
2.9%
Not planned
13 Feb 2026
Teel Randy President and CEO
Sold at will
$52.35K 4,403 at 11.89
2.8%
Not planned
13 Feb 2026
Loomis David K Chief Accounting Officer
Sold at will
$12.08K 1,016 at 11.89
3.2%
Not planned
7 Nov 2025
Loomis David K Chief Accounting Officer
Sold at will
$2.27K 230 at 9.89
0.7%
Not planned
24 Jun 2025
Saik Andrew Chief Financial Officer
Sold at will
$43.38K 5,700 at 7.61
3.4%
Not planned
17 Jun 2025
Cacace Angela M Chief Scientific Officer
Sold at will
$19.35K 2,583 at 7.49
1.6%
Not planned
18 Mar 2025
Berkowitz Noah Chief Medical Officer
Sold at will
$74.37K 8,658 at 8.59
7.3%
Not planned
24 Feb 2025
Houston John G President and CEO
Sold at will 2×
$523.88K 31,338 at 16.72
2.6%
Not planned
24 Feb 2025
Taylor Ian President, R&D
Sold at will 2×
$150.75K 9,020 at 16.71
5.4%
Not planned
24 Feb 2025
Cacace Angela M Chief Scientific Officer
Sold at will 2×
$70.24K 4,207 at 16.70
4.1%
Not planned
24 Feb 2025
Loomis David K Chief Accounting Officer
Sold at will
$20.33K 1,214 at 16.75
6.0%
Not planned
7 Nov 2024
Loomis David K Chief Accounting Officer
Sold at will
$6.40K 231 at 27.69
2.8%
Not planned
23 Feb 2024
Houston John G President and CEO
Sold at will
$244.47K 5,196 at 47.05
0.5%
Not planned
23 Feb 2024
Cassidy Sean A Chief Financial Officer
Sold at will
$80.08K 1,702 at 47.05
0.9%
Not planned
23 Feb 2024
Taylor Ian Chief Scientific Officer
Sold at will
$80.03K 1,701 at 47.05
1.1%
Not planned
23 Feb 2024
Peck Ronald Chief Medical Officer
Sold at will
$79.94K 1,699 at 47.05
2.5%
Not planned
8 Nov 2023
Loomis David K Chief Accounting Officer
Sold at will
$3.90K 229 at 17.05
2.7%
Not planned
11 Aug 2023
Peck Ronald Chief Medical Officer
Sold on a plan
$32.29K 1,324 at 24.39
4.2%
Planned (10b5-1)
1 Mar 2023
Houston John G President and CEO
Sold, plan not stated
$173.58K 5,878 at 29.53
0.6%
1 Mar 2023
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$51.53K 1,745 at 29.53
0.9%
1 Mar 2023
Taylor Ian Chief Scientific Officer
Sold, plan not stated
$31.04K 1,051 at 29.53
1.0%
12 Aug 2022
Peck Ronald Chief Medical Officer
Sold, plan not stated
$86.79K 1,258 at 68.99
13.4%
14 Apr 2022
Morrison Briggs Director
Sold, plan not stated 3×
$1.39M 20,960 at 66.44
51.2%
Sold half or more
11 Mar 2022
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$1.05M 15,000 at 70.00
8.5%
4 Mar 2022
Houston John G President and CEO
Sold, plan not stated
$385.17K 6,024 at 63.94
0.7%
4 Mar 2022
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$101.86K 1,593 at 63.94
1.0%
4 Mar 2022
Taylor Ian Chief Scientific Officer
Sold, plan not stated
$55.56K 869 at 63.94
1.0%
15 Feb 2022
Taylor Ian Chief Scientific Officer
Sold, plan not stated 6×
$1.46M 20,000 at 73.02
20.3%
14 Jan 2022
Morrison Briggs Director
Sold, plan not stated 4×
$1.37M 20,960 at 65.55
45.9%
30 Dec 2021
Peck Ronald Chief Medical Officer
Sold, plan not stated 2×
$1.61M 20,000 at 80.61
78.7%
Sold half or more
17 Dec 2021
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$1.05M 15,000 at 70.00
8.7%
16 Dec 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 2×
$5.94M 85,705 at 69.36
31.6%
15 Dec 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 3×
$7.58M 113,536 at 66.81
29.5%
14 Dec 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 3×
$10.30M 156,464 at 65.86
28.9%
15 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 2×
$1.81M 21,284 at 84.87
3.8%
Showing 1–50 of 104. Page 1 of 3 Older →